Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Kenneth Angermeier, MD, has been a Urologist at the Cleveland Clinic Glickman Urological Institute since 1993. He is a member of the Cleveland Clinic Center for Genitourinary Reconstruction, a regional and national referral center for patients with urethral stricture, urethral fistula, Peyronie’s disease, congenital erectile curvature, urinary incontinence and erectile dysfunction. He is also Associate Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
His primary specialty interest is male lower urinary tract and genital reconstruction and prosthetic surgery. Based on an extensive referral network, Dr. Angermeier also has significant expertise in less common conditions such as genital lymphedema and penile and urethral cancer, among others. He lectures nationally and internationally and has written numerous journal articles and over 20 book chapters related to his specialty areas.
Dr. Angermeier received his Doctor of Medicine in 1985 from Indiana University in Indianapolis with highest distinction. After completing a one-year internship in internal medicine at the Indiana University Medical Center, he served a five-year residency in urology at Cleveland Clinic. He then spent two years as a Fellow in Adult and Pediatric Reconstructive Urology at the Devine Center for Genitourinary Reconstruction and Eastern Virginia Medical School in Norfolk, Va.
In addition to full-time clinical responsibilities and resident teaching, Dr. Angermeier has been continually involved in clinical research. His work has been published in various peer-reviewed journals including the Journal of Urology, Urology, BJU International, Annals of Surgery, Urologic Clinics of North America, International Journal of Impotence Research, Urologia Internationalis, Annals of Diagnostic Pathology and the International Journal of Radiation Oncology, Biology and Physics.
Dr. Angermeier has served on the Board of Directors of the Society of Genitourinary Reconstructive Surgeons in the past. He recently completed a 1 year term as President of this organization and continues to be an active member of their Society.
Lower urinary tract reconstructive surgery, Peyronie's Disease, prosthetic surgery, urethral stricture disease, erectile dysfunction, male incontinence, penile cancer, penile curvature, ureteral cancer
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/16/2012, Dr. Angermeier has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.